In the German model project,
severely dependent drug addicted patients
receive injectable heroin as medication on a trial basis
within the framework of a
scientific study. A parallel control group receives the
methadone. Both groups receive regular medical care and
psychosocial treatment. Target group are those drug dependent
were not successfully treated by any other therapy and/or
whose course of
methadone treatment has not been satisfactory so far.
The model project is a
joint venture of the Federal Health Ministry, the
federal states of Hamburg, Hessen, Niedersachsen and
the cities of Bonn, Frankfurt/Main, Hanover, Karlsruhe,
Cologne and Munich,
and it is accompanied by the professional organisation of
(Bundesärztekammer). Professor Michael Krausz, Centre of
Addiction Research (ZIS) at the University of Hamburg, is in
charge of the
study's scientific design and implementation. Starting October
2003, Prof. Dr. Dieter Naber is director of the clinical
trial (Leiter der klinischen Prüfung, LKP). Clinical
project director is Prof. Dr. Christian Haasen (both ZIS).
[Main page in German]
- An English description of the study design is available for download
- A summary of study reports of the first and second study phase is available here
- Clinical Study Report of the first study phase is available here.
- Clinical Study Report of the second study phase is available here.